22 November 2024

Highlights of FY2016 Presentation: FNN Interview

Open Annual Report 2016

 

Melbourne, Australia; Starpharma Holdings Ltd (ASX:SPL, OTCQX: SPHRY) advises a brief audio interview and presentation with Chief Executive Officer Dr Jackie Fairley will be broadcast today by the Finance News Network.

 

The interview and accompanying presentation highlights the Company’s recent achievements and outlook, including the:

  • Rapidly advancing  DEP™ programs;
  • Expansion of the Company’s DEP™ partnership with AstraZeneca, in addition to its two DEP™ candidates under the existing multiproduct drug delivery license;
  • Signing of two new Targeted DEP™ partnerships with world leading antibody-drug conjugate companies;
  • Signing of an exclusive license and supply agreement for the VivaGel® condom in China for the Government market ;
  • Product launch plans of VivaGel® BV for treatment and rapid relief of Bacterial Vaginosis (BV) symptoms; and
  • Phase 3 clinical trials of VivaGel® BV for the prevention of recurrent BV which are more than 90% enrolled.

 

Listen to the interview here

Download Announcement and Presentation: Starpharma Highlights of FY2016 Presentation (pdf file, 1MB)


This contains certain forward-looking statements.

This website is intended for people seeking information about Starpharma for investment and business purposes. This website contains information about products that may not be available, or approved, in all countries, or may be available under different trademarks, or for different indications. Individuals seeking information about a Starpharma product should visit the relevant product website in their country of residence or consult a healthcare provider. Nothing contained on this site should be considered a solicitation, promotion, or advertisement for any product, including those under development. Any information on this site is not intended to provide medical advice nor should be used as a substitute for the advice provided by a doctor or other healthcare provider.